Loading...
Derniers dépôts
-
-
-
F. Giugliano, A. Bertaut, J. Blanc, A. L. Martin, M. Fournier, et al.. Characteristics, treatment patterns and survival of patients with high-risk early hormone receptor-positive breast cancer in French real-world settings: an exploratory study of the CANTO cohort. ESMO Open, 2024, 9 (12), ⟨10.1016/j.esmoop.2024.103994⟩. ⟨hal-04831746⟩
-
-
-
Anna Patrikidou, Loïc Chaigneau, Nicolas Isambert, Kyriaki Kitikidou, Ryan Shanley, et al.. Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA). BMC Cancer, 2020, 20 (1), pp.117. ⟨10.1186/s12885-020-6548-6⟩. ⟨hal-02872774⟩
-
Romain Chautard, Morgane Caulet, Olivier Bouché, Christophe Borg, Sylvain Manfredi, et al.. Evaluation of serum mid-infrared spectroscopy as new prognostic marker for first-line bevacizumab-based chemotherapy in metastatic colorectal cancer. Digestive and Liver Disease, 2025, 57 (1), pp.141 - 148. ⟨10.1016/j.dld.2024.07.022⟩. ⟨hal-04888278⟩
-
Lucille Vitek, Thomas Goronflot, Caroline Dutriaux, Antoine Deleuze, Yannick Le Corre, et al.. Efficacy and Tolerability of Tebentafusp in Metastatic Uveal Melanoma: A Real-life Retrospective Multicentre Study. Acta Dermato-Venereologica, 2024, 104, pp.adv41297. ⟨10.2340/actadv.v104.41297⟩. ⟨inserm-04839709⟩
-
Françoise Revillion, Michael T. Parsons, Emma Tudini, Hongyan Li, Eric Hahnen, et al.. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification. Human Mutation, 2019, 40 (9), pp.1557-1578. ⟨10.1002/humu.23818⟩. ⟨hal-02194510⟩
-
Olivier de Hertogh, Guillaume Le Bihan, Thomas Zilli, Samuel Palumbo, Marjory Jolicoeur, et al.. Consensus Delineation Guidelines for Pelvic Lymph Node Radiation Therapy of Prostate Cancer : On Behalf of the Francophone Group of Urological Radiation Therapy (GFRU). International Journal of Radiation Oncology, Biology, Physics, 2024, 118 (1), pp.29-40. ⟨10.1016/j.ijrobp.2023.07.020⟩. ⟨hal-04813729⟩
-
Ingrid Masson, Laurène Larriviere, Marc-André Mahé, David Azria, Pascal Pommier, et al.. Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer. Clinical and Translational Radiation Oncology, 2024, 44, pp.100702. ⟨10.1016/j.ctro.2023.100702⟩. ⟨hal-04813716⟩
-
Nicolas Penel, Olivier Mir, Jennifer Wallet, Isabelle Ray-Coquard, Axel Le Cesne, et al.. A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib. European Journal of Cancer, 2020, 126, pp.45-55. ⟨10.1016/j.ejca.2019.12.001⟩. ⟨hal-03623680⟩
-
Loig Vaugier, Elvire Martin-Mervoyer, Loic Ah-Thiane, Martin Langé, Luc Ollivier, et al.. How to contour the different heart subregions for future deep-learning modeling of the heart: A practical pictorial proposal for radiation oncologists. Clinical and Translational Radiation Oncology, 2024, 45, pp.100718. ⟨10.1016/j.ctro.2023.100718⟩. ⟨hal-04791592⟩
-
Olivier Bylicki, Florian Guisier, Arnaud Scherpereel, Catherine Daniel, Aurélie Swalduz, et al.. Real-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04–2021) trial. Lung Cancer, 2024, 194, pp.107866. ⟨10.1016/j.lungcan.2024.107866⟩. ⟨hal-04751314⟩
-
J. Guigay, C. Ortholan, D. Vansteene, D. Cupissol, C. Even, et al.. Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial. The Lancet. Healthy longevity, 2024, 5 (3), pp.e182--e193. ⟨10.1016/s2666-7568(23)00284-2⟩. ⟨hal-04661312⟩
-
Joël Guigay, Hervé Le Caer, François-Régis Ferrand, Lionel Geoffrois, Esma Saada-Bouzid, et al.. Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial. The Lancet. Healthy longevity, 2024, 5 (6), pp.e392-e405. ⟨10.1016/S2666-7568(24)00048-5⟩. ⟨hal-04578230⟩
-
-
Sue Cheeseman, Bethany Levick, Will Sopwith, Hayley Fenton, Eun Ji Nam, et al.. Ovarian Real-World International Consortium (ORWIC): A multicentre, real-world analysis of epithelial ovarian cancer treatment and outcomes. Frontiers in Oncology, 2023, 13, pp.1114435. ⟨10.3389/fonc.2023.1114435⟩. ⟨hal-04756405⟩
-
-
Nombre de documents
287
Nombre de notices
317
Evolution des dépôts
![Chargement de la page](/img/loading.gif)
Répartition des dépôts par type de document
![Chargement de la page](/img/loading.gif)